HealthEquity, Inc. — Form 8-K Summary
Reporting context: Current report dated October 5, 2026; signed October 9, 2026. The filing reports a management change.
Management change
HealthEquity terminated Chief Commercial Officer Michael Fiore without cause, effective October 5, 2026. His responsibilities will be redistributed among other members of the management team.
Financial and operating information
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial performance figures, and does not quantify the financial impact of the departure.
Severance, equity, and contingencies
Mr. Fiore is eligible for previously negotiated severance payments and benefits described in the company’s May 13, 2026 proxy statement, subject to his execution, delivery, and non-revocation of a release and continued compliance with specified restrictive covenants. His outstanding equity awards will be treated under the applicable stock incentive plans and award agreements.
The filing provides no new guidance or outlook and does not describe other risks or contingencies related to the departure.
Investor items to verify
- Review the May 13, 2026 proxy statement for the severance terms and benefits.
- Review the applicable stock incentive plans and award agreements for treatment of Mr. Fiore’s outstanding awards.
- Monitor subsequent filings or disclosures for updates on management responsibilities or any quantified financial impact.